Logo-apb
Adv Pharm Bull. 2019;9(4): 559-570. doi: 10.15171/apb.2019.064
PMID: 31857959        PMCID: PMC6912187

Research Article

Dissolution Enhancement of Atorvastatin Calcium by Cocrystallization

Reham Al-Kazemi 1, Yacoub Al-Basarah 1, Aly Nada 1 * ORCID

Cited by CrossRef: 19


1- Shi X, Wang C, Chen Q, Shen S, Song S, Zhou X. Improving physicochemical properties of Ibrutinib with cocrystal strategy based on structures and natures of the carboxylic acid co-formers. Journal of Drug Delivery Science and Technology. 2021;63:102554 [Crossref]
2- Rani E, Radha G. Paliperidone-benzamide Cocrystals: Preparation, Characterization, In Vitro/In Vivo Evaluation. NANOASIA. 2022;12(6) [Crossref]
3- AlMuhsin A, Ahad A, Bin Jardan Y, Raish M, Ahmad A, Alkharfy K, Al-Jenoobi F. Quality assessment of different brands of atorvastatin tablets available in Riyadh, Saudi Arabia. BMC Pharmacol Toxicol. 2022;23(1) [Crossref]
4- Rani E, Radha G. Tailoring Physicochemical Properties of Iloperidone by Cocrystallization: Design and Characterization of Novel Cocrystals of Iloperidone and 4- amino Benzoic Acid. DDL. 2023;13(1):24 [Crossref]
5- Ariaeinia M, Rahimpour E, Mirzaeei S, Fathi Azarbayjani A, Jouyban A. Thermodynamic analysis of atorvastatin calcium in solvent mixtures at several temperatures. Physics and Chemistry of Liquids. 2023;61(4):275 [Crossref]
6- Chakraborty S, Dhibar M, Pani A. Crystal Engineering and its Chemistry: An Architectural Approach for Cocrystallization. CMS. 2022;15(3):251 [Crossref]
7- Alrouhayyah R, F. Sheshko T, N. Suslina S, Aisha O. Solid Dispersions: An Effective Technology for Improving Dissolution Kinetics of Poorly Soluble Drugs. RJPT. 2023;:5701 [Crossref]
8- Telange D, Bhaktani N, Hemke A, Pethe A, Agrawal S, Rarokar N, Jain S. Development and Characterization of Pentaerythritol-EudragitRS100 Co-processed Excipients as Solid Dispersion Carriers for Enhanced Aqueous Solubility, In Vitro Dissolution, and Ex Vivo Permeation of Atorvastatin. ACS Omega. 2023;8(28):25195 [Crossref]
9- Fayed N, Goda A, Essa E, El Maghraby G. Chitosan-encapsulated niosomes for enhanced oral delivery of atorvastatin. Journal of Drug Delivery Science and Technology. 2021;66:102866 [Crossref]
10- Tekade A, Mathapati S, Ratnaparkhi M, Kulkarni G. Bioavailability Enhancement of Poorly Aqueous Soluble Atorvastatin Calcium by Solid Dispersion Technique Using a Modified Natural Polymer as a Hydrophilic Carrier. J Pharm Innov. 2023;18(4):2182 [Crossref]
11- Oprica M, Iota M, Daescu M, Fejer S, Negrila C, Baibarac M. Spectroscopic studies on photodegradation of atorvastatin calcium. Sci Rep. 2021;11(1) [Crossref]
12- Alrouhayyah R, F. Sheshko T, N. Suslina S. Improving the Dissolution rate of Mefenamic acid by preparing Solid Dispersions with Polyethylene glycol 4000. RJPT. 2023;:3115 [Crossref]
13- Khafagy E, Motawee A, Ghorab M, Gardouh A. Atorvastatin-loaded pro-nanolipospheres with ameliorated oral bioavailability and antidyslipidemic activity. Colloids and Surfaces B: Biointerfaces. 2023;227:113361 [Crossref]
14- Sherif A, Ibrahim M. Unveiling the Superiority of Innovative Carbonated Self-Nanoemulsifying Drug Delivery Systems in Improving the Stability of Acid-Labile Drugs: Atorvastatin as a Model Drug. Processes. 2024;12(6):1169 [Crossref]
15- Radha-Rani E, Venkata-Radha G. Engineering cocrystals of Paliperidone with enhanced solubility and dissolution characteristics. Arhiv za farmaciju. 2021;71(5):393 [Crossref]
16- Arafa M, Alshaikh R, Abdelquader M, El Maghraby G. Co-processing of Atorvastatin and Ezetimibe for Enhanced Dissolution Rate: In Vitro and In Vivo Correlation. AAPS PharmSciTech. 2021;22(2) [Crossref]
17- Alrouhayyah R, Suslina S. Types of modified release dosage forms. Pharmacy and Pharmaceutical Technology. 2022;(1):49 [Crossref]
18- Butreddy A, Sarabu S, Bandari S, Dumpa N, Zhang F, Repka M. Polymer-Assisted Aripiprazole–Adipic Acid Cocrystals Produced by Hot Melt Extrusion Techniques. Crystal Growth & Design. 2020;20(7):4335 [Crossref]
19- Sopyan I, Layyareza R, Megantara S, Marvita S. Carvedilol solubility enhancement by multicomponent crystallization with coformers of benzoic acid, isonicotinamide, and saccharin. PHAR. 2023;70(2):283 [Crossref]